GYNO-TROSYD VAGINAL TABLET 100 mg

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

TIOCONAZOLE

Available from:

PFIZER PRIVATE LIMITED

ATC code:

G01AF08

Dosage:

100 mg

Pharmaceutical form:

TABLET

Administration route:

VAGINAL

Prescription type:

Pharmacy Only

Manufactured by:

Pfizer Manufacturing Deutschland GmbH

Authorization date:

1989-04-19

Patient Information leaflet

T
YPOPHARMA
458080 GI GTR T MYS/SGP
ub/vm
BLATT
1
Maße: 
148 X 290 MM
Schriftgrösse:
8 PT
Leatus-Code: 
1446
Farbe 1: 
PMS 541 D'BLAU
Farbe 2: 
Farbe 3: 
Geprüft:
Datum:
09.04.2008
PFIZER
GYNO-TROSYD
TIOCONAZOLE
1.0 TRADENAME OF MEDICINAL PRODUCT
GYNO-TROSYD
TM
2.0 QUALITATIVE AND QUANTITATIVE COMPOSITION
Tioconazole is available for vaginal administration as 100 mg
tablets.
Tioconazole is a member of the imidazole class of compounds.
Tioconazole Tablet is a bullet-shaped white homogenous tablet.
3.0 PHARMACEUTICAL FORM
Vaginal tablets.
4.0 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Tioconazole vaginal tablets are indicated for the local treatment of
patients with vulvovaginal
candidiasis (moniliasis).
4.2 Posology and Method of Administration
Tioconazole as tablet (100 mg) should be applied once nightly on
retiring, for the specified dura-
tion of treatment using the applicator supplied. Tioconazole is
effective when applied for 3, 6 or
14 days. Three days treatment effects a cure in most patients. A
repeat course of 3 days treat-
ment may be effective in patients who are improved but not cured by
the first course. In cases
By signing this artwork copy the market confirms
that this document  has been checked complete-
ly
, i.e. the corr
ectness of all aspects (text, dosage
values, spelling, font size etc.) is certified. In case
of alterations the concer
ned parts must be mar-
ked clearly
. The market appr
oval of this document
authorizes the plant to print the contents of this
pr
oof. The market takes full r
esponsibility for
corr
ectness of this print pr
oof
burning and vaginal itching), vaginitis, vulva disorder (including
vulva irritation, vulva swelling,
vulva pain, vulva burning and vulvitis)
4.9 Overdose
In the event of overdosage, general symptomatic and supportive
measures are indicated as
required.
5.0 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic Properties
Tioconazole is a synthetic broad spectrum antifungal agent which, _in
vitro_, is fungicidal to yeasts
and other fungi an